Modulation of TNF-induced macrophage polarization by synovial fibroblasts

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2373-2383

  Donlin, Laura T ^a   Jayatilleke, Arundathi ^a,e   Giannopoulou, Eugenia G ^a,b   Kalliolias, George D ^a,c   Ivashkiv, Lionel B ^a,c,d  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b NEW YORK CITY COLLEGE OF TECHNOLOGY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Weill Cornell Medical Center   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; JANUS KINASE; STAT PROTEIN; TUMOR NECROSIS FACTOR; CXCL10 PROTEIN, HUMAN; CXCL9 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; NUCLEOTIDE SEQUENCE; POLARIZATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM; CELL CULTURE; CLINICAL TRIAL; FEMALE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; IMMUNOLOGY; MALE; PATHOLOGY;

ARTHRITIS, RHEUMATOID; AUTOCRINE COMMUNICATION; CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL9; COCULTURE TECHNIQUES; FEMALE; FIBROBLASTS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERFERON-BETA; JANUS KINASES; MACROPHAGES; MALE; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SYNOVIAL MEMBRANE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907029444     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400486     Document Type: Article

References (59)

1. Frenette, P. S., S. Pinho, D. Lucas, and C. Scheiermann. 2013. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol. 31: 285-316.
2. Le Blanc, K., and D. Mougiakakos. 2012. Multipotent mesenchymal stromal cells and the innate immune system. Nat. Rev. Immunol. 12: 383-396.
3. Kalluri, R., and M. Zeisberg. 2006. Fibroblasts in cancer. Nat. Rev. Cancer 6: 392-401.
4. Kraman, M., P. J. Bambrough, J. N. Arnold, E. W. Roberts, L. Magiera, J. O. Jones, A. Gopinathan, D. A. Tuveson, and D. T. Fearon. 2010. Suppression of antitumor immunity by stromal cells expressing fibroblast activation proteina. Science 330: 827-830.
5. Straussman, R., T. Morikawa, K. Shee, M. Barzily-Rokni, Z. R. Qian, J. Du, A. Davis, M. M. Mongare, J. Gould, D. T. Frederick, et al. 2012. Tumour microenvironment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487: 500-504.
6. Németh, K., A. Leelahavanichkul, P. S. Yuen, B. Mayer, A. Parmelee, K. Doi, P. G. Robey, K. Leelahavanichkul, B. H. Koller, J. M. Brown, et al. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15: 42-49.
7. Jones, S., N. Horwood, A. Cope, and F. Dazzi. 2007. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J. Immunol. 179: 2824-2831.
8. Keating, A. 2012. Mesenchymal stromal cells: new directions. Cell Stem Cell 10: 709-716.
9. McInnes, I. B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365: 2205-2219.
10. Noss, E. H., and M. B. Brenner. 2008. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol. Rev. 223: 252-270.
11. Bottini, N., and G. S. Firestein. 2013. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 9: 24-33.
12. Naylor, A. J., A. Filer, and C. D. Buckley. 2013. The role of stromal cells in the persistence of chronic inflammation. Clin. Exp. Immunol. 171: 30-35.
13. Lee, A., Y. Qiao, G. Grigoriev, J. Chen, K.-H. Park-Min, S. H. Park, L. B. Ivashkiv, and G. D. Kalliolias. 2013. Tumor necrosis factor a induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 65: 928-938.
14. Lefèvre, S., A. Knedla, C. Tennie, A. Kampmann, C. Wunrau, R. Dinser, A. Korb, E. M. Schnäker, I. H. Tarner, P. D. Robbins, et al. 2009. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat. Med. 15: 1414-1420.
15. Müller-Ladner, U., J. Kriegsmann, B. N. Franklin, S. Matsumoto, T. Geiler, R. E. Gay, and S. Gay. 1996. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149: 1607-1615.
16. Filer, A., G. Parsonage, E. Smith, C. Osborne, A. M. Thomas, S. J. Curnow, G. E. Rainger, K. Raza, G. B. Nash, J. Lord, et al. 2006. Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: sitespecific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum. 54: 2096-2108.
17. Tran, C. N., S. G. Thacker, D. M. Louie, J. Oliver, P. T. White, J. L. Endres, A. G. Urquhart, K. C. Chung, and D. A. Fox. 2008. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J. Immunol. 180: 2989-2998.
18. Ivashkiv, L. B. 2013. Epigenetic regulation of macrophage polarization and function. Trends Immunol. 34: 216-223.
19. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311.
20. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
21. Park, S. H., K. H. Park-Min, J. Chen, X. Hu, and L. B. Ivashkiv. 2011. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat. Immunol. 12: 607-615.
22. Feldmann, M. 2009. Translating molecular insights in autoimmunity into effective therapy. Annu. Rev. Immunol. 27: 1-27.
23. Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392.
24. Crow, M. K. 2010. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res. Ther. (12 Suppl. 1): S5.
25. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-723.
26. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294: 1540-1543.
27. Cantaert, T., D. Baeten, P. P. Tak, and L. G. van Baarsen. 2010. Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance. Arthritis Res. Ther. 12: 219.
28. Ivashkiv, L. B. 2003. Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis. Autoimmunity 36: 473-479.
29. Williams, E. L., S. Gadola, and C. J. Edwards. 2009. Anti-TNF-induced lupus. Rheumatology (Oxford) 48: 716-720.
30. Kalliolias, G. D., and K. A. Kirou. 2012. Type I interferons as biomarkers in autoimmune diseases. Biomarkers Med. 6: 137-140.
31. Gordon, R. A., G. Grigoriev, A. Lee, G. D. Kalliolias, and L. B. Ivashkiv. 2012. The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor a and counter-regulated by the synovial fluid microenvironment. Arthritis Rheum. 64: 3119-3128.
32. van der Pouw Kraan, T. C., F. A. van Gaalen, P. V. Kasperkovitz, N. L. Verbeet, T. J. Smeets, M. C. Kraan, M. Fero, P. P. Tak, T. W. Huizinga, E. Pieterman, et al. 2003. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 48: 2132-2145.
33. Ivashkiv, L. B., and X. Hu. 2003. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? Arthritis Rheum. 48: 2092-2096.
34. van der Pouw Kraan, T. C., C. A. Wijbrandts, L. G. van Baarsen, A. E. Voskuyl, F. Rustenburg, J. M. Baggen, S. M. Ibrahim, M. Fero, B. A. Dijkmans, P. P. Tak, and C. L. Verweij. 2007. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann. Rheum. Dis. 66: 1008-1014.
35. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11: 750-761.
36. Ivashkiv, L. B., and L. T. Donlin. 2014. Regulation of type I interferon responses. Nat. Rev. Immunol. 14: 36-49.
37. Yarilina, A., K.-H. Park-Min, T. Antoniv, X. Hu, and L. B. Ivashkiv. 2008. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 9: 378-387.
38. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
39. Trapnell, C., L. Pachter, and S. L. Salzberg. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
40. Trapnell, C., B. A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M. J. van Baren, S. L. Salzberg, B. J. Wold, and L. Pachter. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28: 511-515.
41. Rosengren, S., M. Corr, G. S. Firestein, and D. L. Boyle. 2012. The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon. Ann. Rheum. Dis. 71: 440-447.
42. Hu, X., C. Herrero, W. P. Li, T. T. Antoniv, E. Falck-Pedersen, A. E. Koch, J. M. Woods, G. K. Haines, and L. B. Ivashkiv. 2002. Sensitization of IFN-γ Jak-STAT signaling during macrophage activation. Nat. Immunol. 3: 859-866.
43. Huynh, L., L. Wang, C. Shi, K. H. Park-Min, and L. B. Ivashkiv. 2012. ITAM-coupled receptors inhibit IFNAR signaling and alter macrophage responses to TLR4 and Listeria monocytogenes. J. Immunol. 188: 3447-3457.
44. Huangfu, W.-C., J. Qian, C. Liu, J. Liu, A. E. Lokshin, D. P. Baker, H. Rui, and S. Y. Fuchs. 2012. Inflammatory signaling compromises cell responses to interferon a. Oncogene 31: 161-172.
45. Pello, O. M., M. De Pizzol, M. Mirolo, L. Soucek, L. Zammataro, A. Amabile, A. Doni, M. Nebuloni, L. B. Swigart, G. I. Evan, et al. 2012. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood 119: 411-421.
46. Buckley, C. D. 2011. Why does chronic inflammation persist: an unexpected role for fibroblasts. Immunol. Lett. 138: 12-14.
47. Tran, C. N., M. J. Davis, L. A. Tesmer, J. L. Endres, C. D. Motyl, C. Smuda, E. C. Somers, K. C. Chung, A. G. Urquhart, S. K. Lundy, et al. 2007. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum. 56: 1497-1506.
48. Pilling, D., A. N. Akbar, J. Girdlestone, C. H. Orteu, N. J. Borthwick, N. Amft, D. Scheel-Toellner, C. D. Buckley, and M. Salmon. 1999. Interferon-β mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 29: 1041-1050.
49. Kiener, H. P., G. F. Watts, Y. Cui, J. Wright, T. S. Thornhill, M. Skö ld, S. M. Behar, B. Niederreiter, J. Lu, M. Cernadas, et al. 2010. Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in threedimensional organ culture. Arthritis Rheum. 62: 742-752.
50. Lee, D. M., H. P. Kiener, S. K. Agarwal, E. H. Noss, G. F. Watts, O. Chisaka, M. Takeichi, and M. B. Brenner. 2007. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 315: 1006-1010.
51. Maurano, M. T., R. Humbert, E. Rynes, R. E. Thurman, E. Haugen, H. Wang, A. P. Reynolds, R. Sandstrom, H. Qu, J. Brody, et al. 2012. Systematic localization of common disease-associated variation in regulatory DNA. Science 337: 1190-1195.
52. Chen, X., I. Barozzi, A. Termanini, E. Prosperini, A. Recchiuti, J. Dalli, F. Mietton, G. Matteoli, S. Hiebert, and G. Natoli. 2012. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl. Acad. Sci. USA 109: E2865-E2874.
53. Wang, H., J. Brown, C. A. Garcia, Y. Tang, M. R. Benakanakere, T. Greenway, P. Alard, D. F. Kinane, and M. Martin. 2011. The role of glycogen synthase kinase 3 in regulating IFN-β-mediated IL-10 production. J. Immunol. 186: 675-684.
54. Hamilton, J. A., and A. Achuthan. 2013. Colony stimulating factors and myeloid cell biology in health and disease. Trends Immunol. 34: 81-89.
55. Hamilton, J. A., and P. P. Tak. 2009. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 60: 1210-1221.
56. Wynn, T. A., A. Chawla, and J. W. Pollard. 2013. Macrophage biology in development, homeostasis and disease. Nature 496: 445-455.
57. Martinez, F. O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27: 451-483.
58. Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122: 787-795.
59. Brennan, F. M., D. Chantry, A. Jackson, R. Maini, and M. Feldmann. 1989. Inhibitory effect of TNF α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2: 244-247.